Target intelligence / Profile preview

Cytosine (C)

Target
C
Molecular classification
Pyrimidine nucleobase, Nucleobase, Small molecule
01

Overview

Cytosine is a fundamental pyrimidine nucleobase that serves as one of the four primary building blocks of DNA and RNA. In the DNA double helix, it pairs specifically with guanine through three hydrogen bonds, a critical interaction for maintaining the structural integrity and accurate replication of the genome (Genome.gov, 2024). Beyond its role in genetic coding, cytosine is the central substrate for DNA methylation, an essential epigenetic mechanism where the addition of a methyl group to the 5-position of the cytosine ring regulates gene expression and cellular identity (NIH, 2023). While cytosine itself is a metabolite and not a traditional therapeutic target like a protein receptor or enzyme, it is the structural basis for a wide array of nucleoside analog drugs. These pharmacological agents, such as cytarabine and gemcitabine, are designed to mimic cytosine and are used to treat various malignancies and viral infections by disrupting nucleic acid synthesis or modulating DNA methylation patterns (DrugBank, 2024; PubChem, 2024).

Other names
4-aminopyrimidin-2(1H)-one4-amino-2-hydroxypyrimidineCyt71-30-7
02

Mechanism of action

Nucleoside analogs act as antimetabolites by being phosphorylated into active triphosphates that compete with natural cytosine for incorporation into DNA or RNA, leading to chain termination or DNA damage; others act as suicide inhibitors of DNA methyltransferases (DNMTs) to reverse gene silencing (StatPearls, 2023; DrugBank, 2024).

03

Biological functions

Genetic information storageDNA replicationRNA transcriptionEpigenetic regulation (DNA methylation)Intracellular signaling (as CTP/CDP)
04

Disease associations

Cancer (via epigenetic dysregulation and mutations)Viral infectionsGenetic disorders (e.g., C-to-T transitions)
05

Safety considerations

Myelosuppression (anemia, leukopenia, thrombocytopenia) (StatPearls, 2023)Gastrointestinal toxicityHepatotoxicityNeurotoxicity (e.g., cerebellar syndrome with high-dose cytarabine)Teratogenicity
06

Interacting drugs

Cytarabine

7 more in the full profile.

07

Biomarkers

Cytidine deaminase (CDA) expression levels (PubChem, 2024)DNA methylation status (e.g., CpG island methylator phenotype) (NIH, 2023)TP53 mutation statusMicrosatellite instability (MSI) status

Beyond the preview

Go deeper on Cytosine (C).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytosine (C).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call